Dizal Pharmaceutical(SH:688192) Zheng Quan Zhi Xing·2025-09-05 08:09Core Viewpoint - The company, Dizalpharma, is set to hold a collective performance briefing for the first half of 2025 on September 16, 2025, to discuss its operational results and financial status with investors [1][2]. Group 1: Meeting Details - The meeting will take place on September 16, 2025, from 15:00 to 17:00 [1][2]. - It will be held at the Shanghai Stock Exchange Roadshow Center, accessible via the website [1][2]. - The format of the meeting will be an interactive online session [2]. Group 2: Participation Information - Investors can submit questions from September 9, 2025, to September 15, 2025, via the Roadshow Center website or through the company's email [3]. - The company will address commonly asked questions during the briefing [3]. Group 3: Participants - Key participants include the Chairman and General Manager, Dr. Zhang Xiaolin, and the Secretary of the Board and CFO, Mr. Lv Hongbin, along with independent directors [2]. Group 4: Contact Information - For inquiries, investors can contact the Board Office via phone or email [3].